知镜 Cognispect · 医学文献与研究工作台

Chitosan-hyaluronic acid nanoparticles with time-dependent mucoadhesive and mucus penetrating behaviour to overcome pathological lung mucus.

Barretta M, Della Sala F, Marino G, di Gennaro M, Longobardo G, Paradiso R, Borriello G, Borzacchiello A.
Biomaterials science · 2026-11-10 · PMID 42936924

文献摘要

Bacterial infections are a major complication in pulmonary diseases such as chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS), aggravated by multidrug-resistant bacteria and the presence of pathological mucus that limits antibiotics efficacy. To address this challenge, drug-free chitosan/hyaluronic acid (CS/HA) nanoparticles were developed through a one-step ionic gelation method. By modulating the CS/HA ratio and HA molecular weight, stable, spherical nanoparticles with sizes ranging from 75 to 210 nm and positive ζ-potentials between +22 and +34 mV were obtained. FTIR confirmed electrostatic stabilization. The nanoparticles exhibited a unique time-dependent behavior: initial adherence to pathological mucus for local retention, followed by a hydration-driven surface rearrangement enabling mucus barrier penetration. This sequential mucoadhesive-to-mucus-penetrating transition is reported for the first time for a drug-free carbohydrate network. Biological assays demonstrated excellent biocompatibility with healthy and diseased human lung fibroblasts (HLF, HLF COPD and A549), alongside significant antioxidant activity. Moreover, the nanoparticles exerted dose-dependent, intrinsic antimicrobial effects against major respiratory pathogens, including Staphylococcus aureus and Pseudomonas aeruginosa . Overall, by engineering a dynamically adaptive interface, this work crucially resolves the historical trade-off between mucosal retention and diffusion, establishing a promising nanotherapeutic strategy for combating multidrug-resistant pulmonary infections directly at the mucus site.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。